Pear Therapeutics- Warrants (01/12/2026) Overview

Pear Therapeutics- Warrants (01/12/2026) Research & Development

Research & Development expenses for PEARW.

Quarterly R&D Expenses

$11.94M

↓ 67.76% YoY

As of Dec 31, 2022

Annual R&D Expenses (TTM)

$48.31M

↑ 30.43% YoY

Trailing 12 months ending Dec 31, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin